Source: CureToday articles
Patient and disease-related factors influence surgical recovery and treatment outcomes after Keytruda and Padcev in advanced urothelial cancer.
Recent Content
- Asembia AXS25: Navigating the Future of Cell and Gene Therapies
- Asembia AXS25: Addressing Health Equity in Specialty Pharmacy Services
- Recapping Every FDA Approval Announced in April for Cancer Care
- Understanding Cancer Changes and Testing: How Testing Guides Your Metastatic Breast Cancer Treatment
- FDA Approves Atzumi, Nasal Powder Formulation of DHE, for Acute Treatment of Migraine
- AACR 2025: Liposomal Annamycin May Enhance Chemotherapy Efficacy Across Hematologic and Solid Tumors
- Managing Fatigue During Breast Cancer Treatment: Tips for Conserving Energy
- The Impact of Breast Cancer on Self-Image
- Advances in surgical techniques and targeted therapies for Pancreatic Cancer
- Triage Health Conference: Free Education to Navigate Health Care